Constellation Wealth Advisors’s AbbVie ABBV Stock Holding History

Constellation Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$572K	Hold	10,506	–	–	0.06%	61
2015 Q2	$706K	Sell	10,506 -2,171	-17%	-$142K	0.06%	130
2015 Q1	$742K	Buy	12,677 +625	+5%	+$37.8K	0.07%	131
2014 Q4	$789K	Buy	12,052 +333	+3%	+$21K	0.07%	128
2014 Q3	$677K	Hold	11,719	–	–	0.06%	117
2014 Q2	$661K	Sell	11,719 -2,154	-16%	-$113K	0.07%	114
2014 Q1	$713K	Hold	13,873	–	–	0.07%	132
2013 Q4	$733K	Sell	13,873 -284	-2%	-$14K	0.07%	137
2013 Q3	$633K	Buy	14,157 +1,725	+14%	+$76.5K	0.07%	129
2013 Q2	$514K	Buy	+12,432	New	+$544K	0.06%	136

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Constellation Wealth Advisors's ABBV Position: Q3 2015 in Review

Constellation Wealth Advisors held its AbbVie (ABBV) position steady in Q3 2015 at 10,506 shares worth $572K. The position accounts for 0.06% of the portfolio, ranked #61.

Constellation Wealth Advisors first reported a position in ABBV in Q2 2013 and has held it in 10 quarters since. The position peaked at $789K in Q4 2014. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

Constellation Wealth Advisors held 10,506 shares of AbbVie worth $572K as of Q3 2015.
Constellation Wealth Advisors left its AbbVie share count unchanged in Q3 2015.
AbbVie made up 0.06% of Constellation Wealth Advisors's portfolio in Q3 2015, its #61 holding.
Constellation Wealth Advisors first reported a position in AbbVie in Q2 2013 and has held it in 10 quarters since.
Constellation Wealth Advisors's AbbVie position peaked at $789K in Q4 2014.
1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Constellation Wealth Advisors's 13F filing for Q3 2015, filed 9 Nov 2015.